Literature DB >> 10370873

Cardioprotection of red wine: role of polyphenolic antioxidants.

D K Das1, M Sato, P S Ray, G Maulik, R M Engelman, A A Bertelli, A Bertelli.   

Abstract

Epidemiological studies suggest that the consumption of wine, particularly of red wine, reduces the incidence of mortality and morbidity from coronary heart disease. This has given rise to what is now popularly termed the "French paradox". The cardioprotective effect has been attributed to antioxidants present in the polyphenol fraction of red wine. Grapes contain a variety of antioxidants, including resveratrol, catechin, epicatechin and proanthocyanidins. Of these, resveratrol is present mainly in grape skin while proanthocyanidin is present in the seeds. In this report, we provide evidence that red wine extract as well as resveratrol and proanthocyanidins are equally effective in reducing myocardial ischemic reperfusion injury, which suggests that these red wine polyphenolic antioxidants play a crucial role in cardioprotection.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10370873

Source DB:  PubMed          Journal:  Drugs Exp Clin Res        ISSN: 0378-6501


  41 in total

1.  Pleiotropic mechanisms facilitated by resveratrol and its metabolites.

Authors:  Barbara Calamini; Kiira Ratia; Michael G Malkowski; Muriel Cuendet; John M Pezzuto; Bernard D Santarsiero; Andrew D Mesecar
Journal:  Biochem J       Date:  2010-07-15       Impact factor: 3.857

2.  Cardioprotection by resveratrol: a review of effects/targets in cultured cells and animal tissues.

Authors:  Joseph M Wu; Tze-Chen Hsieh; Zhirong Wang
Journal:  Am J Cardiovasc Dis       Date:  2011-04-27

3.  Longevity nutrients resveratrol, wines and grapes.

Authors:  Istvan Lekli; Diptarka Ray; Dipak K Das
Journal:  Genes Nutr       Date:  2009-09-04       Impact factor: 5.523

Review 4.  Botanical flavonoids on coronary heart disease.

Authors:  Chong-Zhi Wang; Sangeeta R Mehendale; Tyler Calway; Chun-Su Yuan
Journal:  Am J Chin Med       Date:  2011       Impact factor: 4.667

Review 5.  News from Tartary: an ethnopharmacological approach to drug and therapeutic discovery.

Authors:  Nicholas Moore; Nawel Hamza; Benedicte Berke; Anwar Umar
Journal:  Br J Clin Pharmacol       Date:  2016-07-24       Impact factor: 4.335

Review 6.  Resveratrol and diabetic cardiac function: focus on recent in vitro and in vivo studies.

Authors:  Belma Turan; Erkan Tuncay; Guy Vassort
Journal:  J Bioenerg Biomembr       Date:  2012-04       Impact factor: 2.945

7.  Potential therapeutic target for malignant paragangliomas: ATP synthase on the surface of paraganglioma cells.

Authors:  Stephanie Mj Fliedner; Chunzhang Yang; Eli Thompson; Mones Abu-Asab; Chang-Mei Hsu; Gary Lampert; Lee Eiden; Arthur S Tischler; Robert Wesley; Zhengping Zhuang; Hendrik Lehnert; Karel Pacak
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

Review 8.  Alcohol consumption and risk of coronary heart disease among individuals with type 2 diabetes.

Authors:  M Tanasescu; F B Hu
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

9.  Inhibitory effect of resveratrol on angiotensin II-induced cardiomyocyte hypertrophy.

Authors:  Tzu-Hurng Cheng; Ju-Chi Liu; Heng Lin; Neng-Lang Shih; Yen-Ling Chen; Meng-Ting Huang; Paul Chan; Ching-Feng Cheng; Jin-Jer Chen
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-12-09       Impact factor: 3.000

10.  Crystal structure of quinone reductase 2 in complex with resveratrol.

Authors:  Leonid Buryanovskyy; Yue Fu; Molly Boyd; Yuliang Ma; Tze-chen Hsieh; Joseph M Wu; Zhongtao Zhang
Journal:  Biochemistry       Date:  2004-09-14       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.